+
Trans-olefination of the Dipalladium Moiety [Pd2Ln]2
A R T I C L E S
5-E,Z,E-antifacial
Table 1. X-ray Crystallographic Data of 1, 3b, and
5-E,Z,E-Antifacial
and crystallization from CH2Cl2/Et2O gave a yellow powder (89.8 mg),
which contained 5-E,Z,E-antifacial and 5-E,E,E-antifacial. The
supernatant was separated from the powder, and Et2O was added.
Crystallization from this solution gave yellow microcrystals of 5-E,Z,E-
1
3b
formula
fw
C
12H18N6B2F8Pd2
C
46H44N2P4F12Pd2
C22H36N4B2F8Pd2
742.96
antifacial (446.8 mg, 76% yield). H and 13C{1H} NMR spectra of
1
632.72
1189.4
space group
a, Å
b, Å
P21/a (No. 14)
10.0193(6)
20.799(1)
12.0023(7)
C2/c (No. 15)
32.791(4)
8.962(2)
Pbca (No. 61)
17.2416(3)
12.1588(3)
29.5145(5)
this crystal in CD3CN showed the presence of two intra-series isomers
(93/7 at 25 °C).42,43 For major isomer: 1H NMR (CD3CN) δ ) 6.02
(m), 4.22 (d, J ) 11.6 Hz), 4.11 (m), 1.16 (s). 13C{1H} NMR
(CD3CN) δ ) 110.1 (s), 102.4 (s), 76.9 (s), 34.4 (s), 29.8 (s). For minor
isomer: 1H NMR (CD3CN) δ ) 5.53 (m), 4.68 (d, J ) 12.7 Hz), 4.35
(m), 1.15 (s). 13C{1H} NMR (CD3CN) δ ) 105.4 (s), 100.7 (s), 73.5
(s), 34.6 (s), 29.9 (s). Anal. Calcd for Pd2C22H36N4B2F8: C, 35.56; H,
4.88; N, 7.54. Found: C, 35.65; H, 4.84; N, 7.72.
c, Å
19.133(3)
R, deg
â, deg
γ, deg
V, Å3
112.696(2)
113.577(10)
2307.5(3)
4
1.821
5153(1)
4
1.533
8.99
296
6187.3(4)
8
1.595
12.29
277
Z
D(calcd), g/cm3
µ(Mo KR), mm-1 16.33
Synthesis of 5-E,E,E-Antifacial. To a solution of [Pd2(CH3CN)6]-
[BF4]2 (1) (500.0 mg, 0.790 mmol) in CH2Cl2 (40 mL) was added
(E,E,E)-DBHT (457.6 mg, 2.371 mmol), and the mixture was stirred
for 5 h at room temperature. The reaction mixture was filtered, and
the volatiles were removed from the filtrate in vacuo. To the residue
was added CH2Cl2 (200 mL), and the suspension was stirred overnight.
The mixture was then concentrated, and Et2O was added. The
supernatant was decanted, and the residue was washed with Et2O. The
residue was then dissolved in CH3CN, the solution was filtered, and
toluene was added to generate a yellow precipitate. Recrystallization
from CH3CN/CH2Cl2/toluene gave a yellow powder of 5-E,E,E-
antifacial (314.1 mg, 54% yield) at the bottom of the vessel. The yellow
crystalline materials on the wall of the vessel were a mixture of 5-E,Z,E-
temp, K
R1
273
0.041
0.077
0.036
H1), 5.03 (dd, J ) 13.6 Hz, J ) 9.2 Hz, H6), 4.42 (dd, J ) 11.2 Hz,
J ) 10.8 Hz, H4, 1H), 3.89 (dd, J ) 13.6 Hz, J ) 10.8 Hz, H5, 1H),
3.72 (dd, J ) 14.8 Hz, J ) 7.2 Hz, H2, 1H), 3.43 (dd, J ) 11.2 Hz, J
) 7.2 Hz, H3, 1H), 1.95 (s, CH3CN, 3H), 1.64 (s, CH3CN, 3H), 0.78
(s, t-Bu, 9H), 0.61 (s, t-Bu, 9H). 31P{1H} NMR (CD2Cl2, -40 °C) δ )
31.3 (d, J ) 12.5 Hz), 22.1 (d, J ) 12.5 Hz). 13C{1H} NMR (CD2Cl2,
25 °C) δ ) 135.3-129.7, 125.3 (s, CH3CN), 123.3 (s, C6), 113.5 (s,
C1), 108.2 (s, C2 or C5), 108.0 (s, C2 or C5), 80.3 (s, C3), 66.2 (s, C4),
34.7 (d, J ) 3.1 Hz, C(CH3)3), 34.1 (d, J ) 3.8 Hz, C(CH3)3), 30.3 (d,
J ) 4.6 Hz, C(CH3)3), 30.0 (d, J ) 3.8 Hz, C(CH3)3), 2.8 (s, CH3CN).
Anal. Calcd for Pd2C54H60N2P2B2F8: C, 54.71; H, 5.10; N, 2.36.
Found: C, 54.89; H, 5.15; N, 2.35.
1
antifacial and 5-E,E,E-antifacial. H NMR (CD3CN) δ ) 5.84 (m),
4.26 (d, J ) 12.4 Hz), 4.06 (m), 1.14 (s). 13C{1H} NMR (CD3CN) δ
) 112.6 (s), 102.0 (s), 79.7 (s), 34.3 (s), 29.8 (s). Anal. Calcd for
Pd2C22H36N4B2F8: C, 35.56; H, 4.88; N, 7.54. Found: C, 35.61; H,
4.88; N, 7.48.
Synthesis of (E,Z,E)-DBHT. (E,Z,E)-DBHT was conveniently
obtained by the dipalladium-mediated isomerization from (E,E,E)-
DBHT. To a solution of 5-E,E,E-antifacial (300.0 mg, 0.404 mmol)
in CH3CN (10 mL) was added dppm (294.9 mg, 0.767 mmol), and the
mixture was stirred for 10 min at 0 °C. The volatiles were removed in
vacuo, and cold pentane (-20 °C) was added to the residue. The
suspension was filtered immediately, and the volatiles were removed
in vacuo to give a colorless powder of (E,Z,E)-DBHT (49.5 mg, 81%
yield). NMR data were found in the literature.41b The compound that
remained on the filter funnel was [Pd2(dppm)2(CH3CN)2][BF4]2.
Generation of 7-E,Z,E-Antifacial. In an NMR tube, 5-E,Z,E-
antifacial (7.0 mg, 0.0094 mmol) and PPh3 (4.9 mg, 0.0188 mmol)
were added, and CD3CN (0.5 mL) was added. The temperature of the
tube was kept at -40 °C. After 5 min, 5-E,Z,E-antifacial disappeared,
and only 7-E,Z,E-antifacial was observed as a mixture of two isomers
(>95/<5). For major: 1H NMR (CD3CN) δ ) 7.6-7.4 (m), 5.79 (br),
3.92 (br), 1.69 (br), 0.92 (br s). 31P{1H} NMR (CD3CN) δ ) 20.6 (s).
For minor: 1H NMR (CD3CN) δ ) 7.19, 6.98, 4.70, 4.42, 4.31, 3.46,
3.06. Only these signals were detected. 31P{1H} NMR (CD3CN) δ )
18.2 (only one signal was detected).
Synthesis of 8-E,E,E-Meso. To a solution of [Pd2(CH3CN)6][BF4]2
(1) (243.4 mg, 0.385 mmol) in CH2Cl2 (30 mL) was added (E,E,E)-
DPHT (247.1 mg, 1.064 mmol), and the mixture was stirred for 2 h at
room temperature. The reaction mixture was filtered, and crystallization
from CH2Cl2/Et2O gave a red powder of 8-E,E,E-meso (251.8 mg,
77% yield). 1H NMR (CD2Cl2) δ ) 7.46 (t), 7.05 (t), 6.78 (d), 6.76 (d,
J ) 13.8 Hz), 5.26 (m), 3.98 (m). 13C{1H} NMR (CD2Cl2) δ ) 132.0
(s), 130.6 (br s), 130.0 (s), 129.7 (s), 129.4 (s), 98.9 (s), 93.1 (s). Anal.
Calcd for Pd2C36H32B2F8: C, 50.80; H, 3.79. Found: C, 50.51; H, 3.96.
A single crystal suitable for X-ray analysis was obtained by recrystal-
lization from CH2Cl2/t-Bu-benzene/n-hexane. 1H NMR data of 8-E,E,E-
rac: 1H NMR (CD2Cl2) δ ) 5.95 (d, J ) 13.5 Hz), 5.79 (m), 3.67
(m).
Synthesis of 7-E,E,E-Antifacial. To a solution of 5-E,E,E-antifacial
(100.0 mg, 0.135 mmol) in CH3CN (3 mL) was added PPh3 (70.6 mg,
0.269 mmol). The color immediately changed from yellow to orange.
The mixture was stirred for 5 min, and the reaction mixture was filtered
and poured into Et2O to afford pale yellow precipitates. The powder
was then washed with Et2O and dried in vacuo to afford 7-E,E,E-
antifacial (127 mg, 79% yield). A single crystal suitable for X-ray
analysis was obtained by recrystallization from CH2Cl2/benzene. For
major: 1H NMR (CD2Cl2, -40 °C) δ ) 7.7-7.2 (m), 4.69 (m, H2,
2H), 3.95 (dd, J ) 13.2 Hz, J ) 8.4 Hz, H1, 2H), 3.61 (m, H3, 2H),
1.58 (s, CH3CN, 6H), 0.59 (s, t-Bu, 18H). 31P{1H} NMR (CD2Cl2, -40
°C) δ ) 30.5 (s). 13C{1H} NMR (CD2Cl2, 25 °C) δ ) 135.3-129.7,
125.3 (s, CH3CN), 119.4 (s, C1), 111.6 (s, C2), 76.1 (s, C3), 34.4 (s,
C(CH3)3), 29.8 (s, C(CH3)3), 2.8 (s, CH3CN). For minor: 1H NMR
(CD2Cl2, -40 °C) δ ) 7.7-7.2, 5.24 (dd, J ) 14.8 Hz, J ) 10.4 Hz,
Synthesis of 8-E,Z,E. The complex 4-E,E,E-antifacial (15.0 mg,
0.0192 mmol) and (E,E,E)-DBHT (1.8 mg, 0.0095 mmol) were placed
in an NMR tube. To the tube was added CD2Cl2 (0.5 mL), and the
tube was supersonicated. After 2 h, the formation of 8-E,Z,E (37%
NMR yield) and 5-E,Z,E-antifacial (41% NMR yield) was observed
with trace (E,Z,E)-DPHT. The complex 8-E,Z,E was obtained as red
crystals together with 5-E,Z,E-antifacial (yellow crystals) from the
reaction of 4-E,E,E-antifacial and (E,E,E)-DBHT in CH2Cl2 with
stirring for 20 min followed by filtration and crystallization from
CH2Cl2/toluene. A red crystal suitable for X-ray diffraction analysis
1
(42) The H and 13C NMR signal patterns of the major and minor isomers are
quite similar (symmetric) to each other, and it is reasonably assumed that
both isomers are the intra-series products, although it cannot be concluded
that the isomer that was structurally determined by X-ray analysis is the
major isomer in CD3CN. For convenience, we abbreviate the two
equilibrated isomers as 5-E,Z,E-antifacial in this Article.
(43) The isolated 5-E,Z,E-antifacial was poorly soluble in CD2Cl2. In the
monitoring reactions of 1 and DBHT in CD2Cl2, however, 5-E,Z,E-
antifacial could be detected because 5-E,Z,E-antifacial becomes soluble
in the presence of free CH3CN released from 1. In these conditions, 5-E,Z,E-
antifacial existed as a mixture of two isomers (major/minor ) 9/1) as
observed in CD3CN.
1
was picked up from the crystalline mixture. H NMR (CD2Cl2) δ )
7.39 (m, p-Ph), 7.17 (d, J ) 13.5 Hz, H1), 6.93 (m, o-, m-Ph), 5.07 (m,
H2), 4.56 (m, H3).
9
J. AM. CHEM. SOC. VOL. 128, NO. 13, 2006 4387